Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

PRP more effective than minoxidil 5% for treating alopecia areata.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Minoxidil helps hair regrowth in alopecia areata safely.

Scalp skin barrier affects hair loss; personalized treatments needed.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

People with hair loss conditions experience more anxiety, depression, and a lower quality of life than those without these conditions.

Trichoscopy helps diagnose and assess the severity of Frontal Fibrosing Alopecia.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Trichoscopy can effectively tell apart tinea capitis and alopecia areata in children by looking for specific hair shapes.

Frontal fibrosing alopecia can cause sudden hair loss on limbs, similar to scalp hair loss.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Regular use of sunscreen may be linked to frontal fibrosing alopecia.

Frontal Fibrosing Alopecia in men is often missed and can come with symptoms like facial bumps and hair loss on eyebrows and limbs.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

The document concludes that more research is needed to understand and treat Beard Alopecia Areata due to limited current knowledge and evidence.